Site: Biliary

Inclusion Criteria:

• No Prior History of Liver/Biliary Cancer
• No Rare Cancers in Controls
• Serum Available
• Pre-Diagnostic Serum Available

Matching Factors:

• Gender
• Race
• Fiscal Year of Blood Draw
• Study Year of Blood Draw

Match Ratio: 2:1

Match Technique: Individual matching only non-cases as controls.

Additional Matching Comments: Matches from 2011-00187 were retained, when possible.

Analytes:

• 1aCore (1.4)
• 1aNS3 (2.5)
• CagA F32 Subfragment
• CagA G27 Subfragment
• Cytotoxin-Associated Gene A
• HH0243
• HH0407
• HH0435
• HH0713
• HH0966
• HH1201
• HH1446
• HP 0010 (G27)
• HP 0073
• HP 0243
• HP 0410
• HP 0537
• HP 0875
• HP 1098
• HP 1104
• HP 1564
• HP 522
• HP0231
• HP0305
• HRAG_00845
• HRAG_01298
• HRAG_01470
• HRAG_01504
• HRAG_01818
• Hepatitis B Core Antibody
• Hepatitis B E-Antigen
• Human Polyomavirus BK VP1
• Hydantoin Utilization Protein
• P167C
• P167D
• Tumor Protein P53
• Vacuolating cytotoxin A

Number of Cases: 185

Number of Controls: 370

---